The Iran war is driving an oil shock — but not a broad supply chain crisis, Goldman Sachs says – Business Insider

NEW YORK (AP) — New York is suing Coinbase and Gemini, two of the newest players in the prediction market industry, arguing that the companies’ unregulated and unlicensed platforms are illegal gambling operations. Attorney General Letitia James’ lawsuit, filed Tuesday in state court in Manhattan, seeks to bar the companies’ platforms from operating in the…

Check out the companies making the biggest moves before the bell: Bank stocks — The group fell broadly after President Donald Trump called for credit card rates to be capped at 10% for one year . Citigroup dropped 4%, while Capital One slid nearly 10%. Bank of America , Wells Fargo and JPMorgan Chase were…

One of the most divisive topics among environmental advocates and researchers is the claim that the growth of rooftop solar leads to a concerning transfer of costs from households that have solar to those that don’t. Most people who have studied this agree there is some shift in costs, but they disagree on how much…

<img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw==" alt=" Photographer: Chesnot/Getty Images ” loading=”eager” height=”640″ width=”960″ class=”yf-1gfnohs loader”> Photographer: Chesnot/Getty Images (Bloomberg) — Wall Street is gearing up to lend massive amounts of money to the biggest players in artificial intelligence — and simultaneously trying to figure out how to protect itself from any bubble that its financing may be helping…

The controversy around Delve appears to have cost the compliance startup its relationship with accelerator Y Combinator. Delve is no longer listed among YC’s directory of portfolio companies, and the Delve page seems to have been removed from the YC website. In addition, the startup’s COO Selin Kocalar posted on X that “YC and Delve…

NEW YORK (AP) — Drugs that treat Type 2 diabetes, HIV and arthritis are among 15 new medications chosen for a Medicare drug price negotiation program that allows the federal government to haggle directly with drug manufacturers, the Trump administration said Tuesday. The drugs selected include some of the medications on which Medicare spends the…